Amgen Financial Diagnostics

Amgen Inc -- USA Stock  

USD 188.01  1.27  0.67%

Amgen Inc diagnostics interface makes it easy to digest most current publicly released information about Amgen as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Amgen price relationship with some important fundamental indicators such as market cap and management efficiency.
About 82.0% of the company shares are held by institutions such as insurance companies. Book value of Amgen Inc was presently as 44.36. The company recorded earning per share (EPS) of 11.07. Amgen Inc last dividend was issued on 2018-02-14. This company had 2:1 split on 1999-11-22. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. For more info on AMGEN please contact Robert Bradway at 805 447-1010 or go to www.amgen.com.

Amgen Inc Alerts

Amgen Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
Over 82.0% of the company shares are held by institutions such as insurance companies
Latest headline from stocknewsgazette.com: Comparing Amgen Inc. and ACADIA Pharmaceuticals Inc.

Amgen Inc Upcoming Events

Upcoming Quarterly ReportApril 27, 2017
Next Earnings ReportJuly 26, 2017

Amgen Inc EPS Estimate

EPSEstimate Date
Quarterly Estimate2.99April 27, 2017

Amgen SEC Filings

Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Departure of Directors or Certain Offices; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Unclassified Corporate Event
Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement

Institutional Investors

Security TypeSharesValue
Schwab Charles Investment Management IncCommon Shares3.3 M574.7 M
Bank Of MontrealCommon Shares2.6 M454.3 M
National Pension ServiceCommon Shares583.7 K101.5 M
Gateway Investment Advisers LlcCommon Shares410.9 K71.5 M
Nisa Investment Advisors LlcCommon Shares319.1 K55.5 M
Gulf International Bank Uk LtdCommon Shares232.6 K40.4 M
Davenport Co LlcCommon Shares221.8 K38.6 M

Market Capitalization

The company currently falls under 'Mega-Cap' category with current market capitalization of 136.48 B.

Profitablity

The company has Profit Margin (PM) of 35.54 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 43.66 % which suggests for every 100 dollars of sales it generated a net operating income of 0.44.

Management Efficiency

Amgen Inc has return on total asset (ROA) of 7.92 % which means that it generated profit of $7.92 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 25.96 % meaning that it created $25.96 on every $100 dollars invested by stockholders.

Stock Holders for Amgen

Information
Ratio
Value
At Risk
NASDAQ USNASDAQ US Rising Dividend Achie 0.0559 (0.72) 
NasdaqNasdaq(0.021) (0.51) 
NASDAQNASDAQ Composite Total Return I 0.11 (0.44) 
Stlmt IDStlmt ID NASDAQ Biotechnology 0.00  0.00 
KnightsKnights of Columbus Large Cap Val Instl(0.22) (0.64) 
FidelityFidelity Advisor Health Care M 0.0942 (0.7) 
XNBINASDAQ Biotechnology Total Retu 0.004 (1.39) 
TempletonTempleton World Adv(0.21) (0.3) 
SPDR SSGASPDR SSGA Gender Diversity ETF(0.0838) (0.33) 
SAGYXClearBridge Aggressive Growth I 0.11 (0.43) 
AmericanAmerican Funds Capital World GrInc R2E(0.19) (0.23) 
AmericanAmerican Funds American Mutual R3(0.19) (0.29) 
AmericanAmerican Funds Capital Income Bldr R2(0.42) (0.25) 
AmericanAmerican Funds Capital Income Bldr R2E(0.41) (0.25) 
HorizonsHorizons NASDAQ 100 Covered Call ETF(0.67) (0.28) 
PWVPowerShares Exchange Traded Fund Trust PowerShares Dynamic Large Cap Value Portfolio 0.00  0.00 
NuveenNuveen Large Cap Value C 0.04 (0.61) 
LMPRXClearBridge Aggressive Growth R 0.14 (0.43) 
LMPFXClearBridge Aggressive Growth FI 0.14 (0.43) 
JanusJanus Henderson Balanced S(0.3) (0.3) 

Technical Drivers

Amgen Inc shows Mean Deviation of 0.6816 and Risk Adjusted Performance of 0.1818. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found eighteen technical drivers for Amgen Inc which can be compared to its rivals. Please confirm Amgen Inc Variance as well as the relationship between Maximum Drawdown and Semi Variance to decide if Amgen Inc is priced correctly providing market reflects its regular price of 188.01 per share. Given that Amgen has Treynor Ratio of 0.3381, we suggest you validate Amgen Inc prevailing market performance to make sure the company can sustain itself at future point.

Amgen Inc Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
  
Execute Study
 
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Amgen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Amgen Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Bonds

Amgen Outstanding Bonds
MaturityCouponRating
031162AA8 8.125%04/01/20978.125
A
031162AV2 5.85%06/01/20175.85
A
031162AW0 6.375%06/01/20376.375
A
031162AX8 6.15%06/01/20186.15
A
031162AY6 6.9%06/01/20386.9
A
031162AZ3 5.7%02/01/20195.7
A
031162BA7 6.4%02/01/20396.4
A
031162BB5 4.5%03/15/20204.5
A
031162BC3 5.75%03/15/20405.75
A
031162BD1 3.45%10/01/20203.45
A
031162BE9 4.95%10/01/20414.95
A
031162BF6 2.3%06/15/20162.3
A
031162BG4 4.1%06/15/20214.1
A
031162BH2 5.65%06/15/20425.65
A
031162BK5 5.15%11/15/20415.15
A
031162BL3 2.5%11/15/20162.5
A
031162BM1 3.875%11/15/20213.875
A
031162BN9 3.625%05/15/20223.625
A
031162BP4 5.375%05/15/20435.375
A
031162BQ2 2.125%05/15/20172.125
A
031162BR0 1.25%05/22/20171.25
A
031162BU3 2.2%05/22/20192.2
A
031162BV1 3.625%05/22/20243.625
A
031162AS9 5.85%06/01/20175.85
A
031162BW9 2.125%05/01/20202.125
NA
031162BX7 2.7%05/01/20222.7
A
031162BY5 3.125%05/01/20253.125
A
031162BZ2 4.4%05/01/20454.4
A

Corporate Filings

Amgen Corporate Reports
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations